Table 4.

Characteristics of economic evaluations by publication period

	1995–2000 (n = 88) No. (%) of studies	2001–2005 (n = 107) No. (%) of studies	1995–2005 (n = 195) No. (%) of studies
By Study Type
Cost effectiveness (life years gained)	41 (47)	32 (30)	73 (37)
Cost effectiveness (clinical outcome)	25 (28)	28 (26)	53 (27)
Cost utility	6 (7)	32 (30)	38 (20)
Cost consequence	11 (13)	10 (9)	21 (11)
Cost minimization	4 (5)	3 (3)	7 (4)
Cost benefit	1 (1)	2 (2)	3 (2)
By Perspective
Societal	15 (17)	23 (22)	38 (20)
Third Party Payer	28 (32)	38 (36)	66 (34)
Health care provider	1 (1)	3 (3)	4 (2)
Patient	1 (1)	1 (1)	2 (1)
Other*	3 (3)	1 (1)	4 (2)
Not stated	40 (46)	41 (38)	81 (42)
By Funding source
Government	20 (23)	31 (29)	51 (26)
Industry	22 (25)	29 (27)	51 (26)
Foundation	10 (11)	5 (5)	15 (8)
Other*	0 (0)	7 (7)	7 (4)
Not stated	36 (41)	35 (33)	71 (36)

* Summarized over extracted categories